References
- Rapp S. R., Feldman S. R., Exum M. L., Fleischer AB J. r., Reboussin D. M. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41((3 Pt 1))401–7
- McDonald C. J., Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99: 469–75
- Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle‐aged, urban, native Swedes. Dermatologica 1986; 172: 298–304
- Henseler T., Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982–6
- Ena P., Madeddu P., Glorioso N., Cerimele D., Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin‐angiotensin system in psoriatic patients. Acta Cardiol 1985; 40: 199–205
- Stern R. S., Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988; 91: 197–201
- Lanse S. B., Arnold G. L., Gowans J. D., Kaplan M. M. Low incidence of hepatotoxicity associated with long‐term, low‐dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio. Dig Dis Sci 1985; 30: 104–9
- Nyfors A., Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non‐methotrexate treated patients. Acta Pathol Microbiol Scand [A] 1976; 84: 253–61
- Centers for Disease Control Prevention. CDC's Diabetes Program – Publications & Products – National Diabetes Fact Sheet – National Estimates on Diabetes. http://www cdc gov 2003 [cited 3 A.D Oct 10]. Available from: URL: http://www.cdc.gov/diabetes/pubs/estimates.htm
- American Heart Association. American Heart Association: Statistical Fact Sheet – Risk Factors. http://www americanheart org 2003 [cited 3 A.D. Oct 10].Available from: URL:http://www.americanheart.org/downloadable/heart/1059111472025FS14HBP3REV7‐03.pdf
- Tracy R. P. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord 2003; 27((Suppl 3))s29–s34
- West S. G. Methotrexate hepatotoxicity. Rheum Dis Clin North Am 1997; 23: 883–915
- Monk B. E., Neill S. M. Alcohol consumption and psoriasis. Dermatologica 1986; 173: 57–60
- Poikolainen K., Reunala T., Karvonen J., Lauharanta J., Karkkainen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men?. BMJ 1990; 300: 780–3
- Poikolainen K., Karvonen J., Pukkala E. Excess mortality related to alcohol and smoking among hospital‐treated patients with psoriasis. Arch Dermatol 1999; 135: 1490–3
- Fleischer AB J. r., Feldman S. R., Rapp S. R., Reboussin D. M., Exum M. L., Clark A. R., et al. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self‐administered psoriasis area severity index scores. J Invest Dermatol 1996; 107: 26–9